Medical News Bulletin | Health News and Medical Research – Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place
Dapagliflozin, a drug originally developed to treat diabetes, shows benefit in patients in heart failure. Dapagliflozin belongs to a relatively new class of drugs, the sodium-glucose co-transporter-2 inhibitors, for treating type 2 diabetes mellitus. This new class of drugs works to reduce blood glucose levels by reducing the reabsorption of glucose in the kidneys. Clinical […]
The post Can a new diabetes drug also treat heart disease? appeared first on Medical News Bulletin | Health News and Medical Research.
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life and that is to make people understand that the conventional method of treating T2DM is not beneficial. Type 2 diabetes is reversible and the best way to reverse T2DM is through diet and lifestyle modifications. He now decided to help people with type 2 diabetes by offering online coaching to reverse their diabetes.
